I’ve been pregnant twice in my 40s and am expecting my fifth child in November. Like most women my age, I was offered — indeed encouraged to have — an amniocentesis orchorionic villous sampling (CVS). But I worry about about procedure-related miscarriage — the small chance that an invasive test (involving a needle in the uterus) could cause the loss of an otherwise healthy child.
Perhaps that’s why I felt such gratitude when I was offered non-invasive prenatal testing (NIPT), a test that can, through a single blood sample, determine with accuracy whether a fetus carries the genes for one of three major chromosome abnormalities. I’ve never been more eager to roll up my sleeve.
Share this article
Read the full, original story here: I Found the ‘Holy Grail’ of Prenatal Testing
